BSX Notícias Forex
Boston Scientific Boosts FY24 Outlook - Update
While reporting financial results for the second quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and sales growth guidance for the full-year 2024.
RTTNews
|
154 dias atrás
Boston Scientific To Acquire Silk Road Medical For $27.50/share In Deal Valued At About $1.16 Bln
Medical device company Boston Scientific Corp. (BSX) announced Tuesday it has entered into a definitive agreement to acquire smaller peer Silk Road Medical, Inc. (SILK) for $27.50 per share, reflecting an enterprise value of approximately $1.16 billion.
RTTNews
|
190 dias atrás
Boston Scientific Boosts FY24 Outlook - Update
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024.
RTTNews
|
245 dias atrás
Boston Scientific Says FTC Issues Second Request Amid Boston Scientific And Axonics Merge Review
Boston Scientific Corp. (BSX) revealed Thursday in a Form 8-K filing with the U.S. Securities and Exchange Commission that the company and Axonics each received a request for additional information from the U.S. Federal Trade Commission (FTC) in connection with the FTC's review of the merger.
RTTNews
|
265 dias atrás
Boston Scientific To Acquire Axonics For $71/shr In All-cash Deal Valued At About $3.7 Bln
Medical technology company Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire peer Axonics, Inc. (AXNX) for $71 per share in an all-cash deal valued at approximately $3.7 billion.
RTTNews
|
352 dias atrás
Boston Scientific To Acquire Relievant Medsystems
Medical technology company Boston Scientific Corp. (BSX) announced Tuesday it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately-held peer. The transaction includes an upfront cash payment of $850 million and undisclosed additional contingent payments based on sales performance over the next three years.
RTTNews
|
463 dias atrás
Boston Scientific Boosts FY23 Adj. EPS, Sales Growth Outlook - Update
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2023.
RTTNews
|
609 dias atrás
Boston Scientific Acquires Obsidio For Undisclosed Terms
Medical technology company Boston Scientific Corp. (BSX) announced Monday the acquisition of privately-held company Obsidio, Inc. that has developed the Gel Embolic Material (GEM) technology used for embolization of blood vessels in the peripheral vasculature.
RTTNews
|
863 dias atrás
Nevro And Boston Scientific Reach $85 Mln Settlement Of Ongoing Intellectual Property Litigations
Medical device makers Nevro Corp. (NVRO) and Boston Scientific Corp. (BSX) announced Monday that they have reached a settlement in all their ongoing intellectual property litigations, including a net payment from Boston Scientific to Nevro of $85 million.
RTTNews
|
877 dias atrás
